Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer
- 1 June 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 151, 162-170
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/03002-7, 2015/06134-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 41 references indexed in Scilit:
- Protein corona significantly reduces active targeting yieldChemical Communications, 2013
- Revealing silver cytotoxicity using Au nanorods/Ag shell nanostructures: disrupting cell membrane and causing apoptosis through oxidative damageRSC Advances, 2012
- Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer researchCancer Letters, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Bladder Cancer Immunotherapy: BCG and BeyondAdvances in Urology, 2012
- Silver nanoparticles: Evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cellsToxicology Letters, 2011
- Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis softwareBioinformatics, 2011
- p38 MAPK Activation, DNA Damage, Cell Cycle Arrest and Apoptosis As Mechanisms of Toxicity of Silver Nanoparticles in Jurkat T CellsEnvironmental Science & Technology, 2010
- Strategies in the design of nanoparticles for therapeutic applicationsNature Reviews Drug Discovery, 2010
- DNA damage response to different surface chemistry of silver nanoparticles in mammalian cellsToxicology and Applied Pharmacology, 2008